• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapeutic exchange of cefotaxime for ceftriaxone: evaluation, implementation, and subsequent cost savings at a 300-bed community hospital.

作者信息

Rawlings R D

机构信息

Mercy Memorial Medical Center, St. Josephs, MI, USA.

出版信息

Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):235-7. doi: 10.1016/0732-8893(95)00099-v.

DOI:10.1016/0732-8893(95)00099-v
PMID:7587046
Abstract

Switching prescriptions from ceftriaxone to cefotaxime resulted in a decreased pharmacy expenditure of $30,190 within 1 year in a 300-bed community hospital. The cost per patient day of treatment was reduced from $38.85 to $26.98 and led to a total cost avoidance of $47,997.

摘要

相似文献

1
Therapeutic exchange of cefotaxime for ceftriaxone: evaluation, implementation, and subsequent cost savings at a 300-bed community hospital.
Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):235-7. doi: 10.1016/0732-8893(95)00099-v.
2
Cefotaxime and ceftriaxone use evaluation in pediatrics. Considerations of cost effectiveness.
Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):231-3. doi: 10.1016/0732-8893(95)00081-k.
3
[Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].头孢曲松与头孢噻肟治疗复杂性泌尿系统感染的成本效益比较研究
Actas Urol Esp. 1997 Jul-Aug;21(7):668-74.
4
[Cost-effectiveness analysis of ceftriaxone and cefotaxime in the treatment of community-acquired pneumonia].
Rev Invest Clin. 2000 Jul-Aug;52(4):418-26.
5
Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients.
S Afr Med J. 1998 Sep;88(9):1046, 1048; author reply 1050-1.
6
Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.头孢噻肟。对其用于治疗感染的药物经济学综述。
Pharmacoeconomics. 1998 Jan;13(1 Pt 1):91-106. doi: 10.2165/00019053-199813010-00009.
7
Antibiotic surveillance: the results of a clinical pharmacy intervention program.抗生素监测：一项临床药学干预项目的结果
Hosp Pharm. 1993 Mar;28(3):206-10, 212.
8
Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.头孢曲松治疗成年住院患者社区获得性肺炎的成本效益。一项基于荟萃分析的药物经济学研究。
S Afr Med J. 1998 Mar;88(3):251-5.
9
Cost savings achieved through cephalosporin use review and restriction.通过头孢菌素使用审查和限制实现成本节约。
Am J Hosp Pharm. 1986 Sep;43(9):2194-7.
10
Cost comparison of single daily i.v. doses of ceftriaxone versus continuous infusion of cefotaxime.
Am J Health Syst Pharm. 1997 Jul 15;54(14):1614-8. doi: 10.1093/ajhp/54.14.1614.

引用本文的文献

1
Modifying provider behavior: a low-tech approach to pharmaceutical ordering.改变医疗服务提供者的行为：一种低成本的药品订购方法。
J Gen Intern Med. 2002 Oct;17(10):792-6. doi: 10.1046/j.1525-1497.2002.20144.x.
2
Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.头孢噻肟。对其抗菌活性和药代动力学特性的重新评估，以及对其每日两次给药治疗轻至中度感染时的治疗效果的综述。
Drugs. 1997 Mar;53(3):483-510. doi: 10.2165/00003495-199753030-00009.